Cargando…
News
Two new combination pediatric vaccines advancing to use in infants Oncolytic viruses successfully delivered intravenously Cuba eliminates hepatitis B among minors under 15 Alzheimer's vaccine trial a success Study: Shingles vaccine safe for patients on immune-suppressing drugs Therapeutic cance...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Landes Bioscience
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551869/ https://www.ncbi.nlm.nih.gov/pubmed/22914446 http://dx.doi.org/10.4161/hv.21700 |
| _version_ | 1782256634032029696 |
|---|---|
| author | Riedmann, Eva M. |
| author_facet | Riedmann, Eva M. |
| author_sort | Riedmann, Eva M. |
| collection | PubMed |
| description | Two new combination pediatric vaccines advancing to use in infants Oncolytic viruses successfully delivered intravenously Cuba eliminates hepatitis B among minors under 15 Alzheimer's vaccine trial a success Study: Shingles vaccine safe for patients on immune-suppressing drugs Therapeutic cancer vaccine against metastatic renal cell carcinoma enters Phase 3 Pfizer’s Men B vaccine shows promise in Phase 2 Biovest initiates formal regulatory approval process for BiovaxID in Europe |
| format | Online Article Text |
| id | pubmed-3551869 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | Landes Bioscience |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-35518692013-01-25 News Riedmann, Eva M. Hum Vaccin Immunother News, Policy and Profiles Two new combination pediatric vaccines advancing to use in infants Oncolytic viruses successfully delivered intravenously Cuba eliminates hepatitis B among minors under 15 Alzheimer's vaccine trial a success Study: Shingles vaccine safe for patients on immune-suppressing drugs Therapeutic cancer vaccine against metastatic renal cell carcinoma enters Phase 3 Pfizer’s Men B vaccine shows promise in Phase 2 Biovest initiates formal regulatory approval process for BiovaxID in Europe Landes Bioscience 2012-08-01 /pmc/articles/PMC3551869/ /pubmed/22914446 http://dx.doi.org/10.4161/hv.21700 Text en Copyright © 2012 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
| spellingShingle | News, Policy and Profiles Riedmann, Eva M. News |
| title | News |
| title_full | News |
| title_fullStr | News |
| title_full_unstemmed | News |
| title_short | News |
| title_sort | news |
| topic | News, Policy and Profiles |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551869/ https://www.ncbi.nlm.nih.gov/pubmed/22914446 http://dx.doi.org/10.4161/hv.21700 |
| work_keys_str_mv | AT riedmannevam news |